Page last updated: 2024-10-30

losartan and Idiopathic Pulmonary Fibrosis

losartan has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Idiopathic Pulmonary Fibrosis: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.

Research Excerpts

ExcerptRelevanceReference
"Patients with idiopathic pulmonary fibrosis and a baseline %FVC of ≥50 % were treated with losartan 50 mg by mouth daily for 12 months."9.16Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project. ( Couluris, M; Gross-King, M; Kinder, BW; Krischer, J; Panos, RJ; Xu, P, 2012)
"Patients with idiopathic pulmonary fibrosis and a baseline %FVC of ≥50 % were treated with losartan 50 mg by mouth daily for 12 months."5.16Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project. ( Couluris, M; Gross-King, M; Kinder, BW; Krischer, J; Panos, RJ; Xu, P, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Couluris, M1
Kinder, BW1
Xu, P1
Gross-King, M1
Krischer, J1
Panos, RJ1

Trials

1 trial available for losartan and Idiopathic Pulmonary Fibrosis

ArticleYear
Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project.
    Lung, 2012, Volume: 190, Issue:5

    Topics: Aged; Aged, 80 and over; Disease Progression; Dyspnea; Exercise Test; Female; Humans; Idiopathic Pul

2012